Another five or six million people will be offered a prescription for statins after NICE confirmed its decision last week to halve the risk of heart disease that makes you eligible for these cholesterol lowering drugs. This is a bad decision if you think that the only consideration was the welfare of patients. If you […]
Statin wars: an outbreak of medical transparency
June 13, 2014 by 10 Comments
Something remarkable happened earlier this week. Open warfare broke out between senior doctors over the benefits of a major government health policy. To prescribe or not to prescribe yet more statins to healthy people? That was the question. Details of the open letter to the head of NICE (the health value-for-money body) challenging its proposal […]
Body of Evidence 
Recent Comments